Atlas Trials

A Study of Second-line Treatment of Postoperative Recurrence and Metastasis of Esophageal Cancer Treated With Apatinib

Clinical trial NCT03787251 · WITHDRAWN

Trial details

NCT number
NCT03787251
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal Neoplasms
Start date
2019-01-01
Primary completion
2020-12-31
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.